Cargando…
Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease
INTRODUCTION: Trimethylamine-N-oxide (TMAO) is a circulating biomarker associated with cardiovascular disease (CVD). Production of TMAO is facilitated by gut microbiota and dependent on micronutrients such as choline, betaine, and L-carnitine, present in foods such as red meat and eggs. HYPOTHESIS:...
Autores principales: | Bean, Lamuel D., Wing, Jeffrey J., Harris, Randall E., Smart, Suzanne M., Raman, Subha V., Milks, M. Wesley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087975/ https://www.ncbi.nlm.nih.gov/pubmed/35538408 http://dx.doi.org/10.1186/s12872-022-02644-3 |
Ejemplares similares
-
Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis
por: Cardona, Andrea, et al.
Publicado: (2019) -
Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2020) -
The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023) -
Trimethylamine-N-Oxide: The Link Between Loop Diuretics and Cardiovascular Outcomes?
por: Adel, Fadi W., et al.
Publicado: (2021) -
Gender-Related Differences in Trimethylamine and Oxidative Blood Biomarkers in Cardiovascular Disease Patients
por: Bordoni, Laura, et al.
Publicado: (2020)